Health-Related Quality-of-Life Results From the Open-Label, Randomized, Phase III ASPIRE Trial Evaluating Carfilzomib, Lenalidomide, and Dexamethasone Versus Lenalidomide and Dexamethasone in Patients With Relapsed Multiple Myeloma

PURPOSE: To determine the effects of carfilzomib, lenalidomide, and dexamethasone (KRd) versus lenalidomide and dexamethasone (Rd) on health-related quality of life (HR-QoL) in the Carfilzomib, Lenalidomide, and Dexamethasone Versus Lenalidomide and Dexamethasone for the Treatment of Patients With R...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Oncol
Main Authors: Stewart, A. Keith, Dimopoulos, Meletios A., Masszi, Tamás, Špička, Ivan, Oriol, Albert, Hájek, Roman, Rosiñol, Laura, Siegel, David S., Niesvizky, Ruben, Jakubowiak, Andrzej J., San-Miguel, Jesus F., Ludwig, Heinz, Buchanan, Jacqui, Cocks, Kim, Yang, Xinqun, Xing, Biao, Zojwalla, Naseem, Tonda, Margaret, Moreau, Philippe, Palumbo, Antonio
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2016
Assuntos:
ORIGINAL REPORTS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5791840/
https://ncbi.nlm.nih.gov/pubmed/27601539
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2016.66.9648
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados